BioNotebook: Alector, Dimension, Discovery Labs, BioMarin/Clovis, Array, CEL-SCI, Otonomy, GlobeImmune

Alector, Dimension raise Series A rounds; Discovery Labs sells $50m in stock; BioMarin, Clovis start PARP inhibitor studies; Array takes ARRY-502 into Phase III; CEL-SCI seeks arbitration with CRO; Otonomy buys tinnitus IP; and GlobeImmune withdraws IPO.

Alector, Dimension raise Series A rounds; Discovery Labs sells $50m in stock; BioMarin, Clovis start PARP inhibitor studies; Array takes ARRY-502 into Phase III; CEL-SCI seeks arbitration with CRO; Otonomy buys tinnitus IP; and GlobeImmune withdraws IPO.

Alector raises Series A cash, taps Adimab antibody discovery engine

More from Anticancer

More from Therapy Areas